Cite
HARVARD Citation
Michels, K. et al. (2023). Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering. Journal for immunotherapy of cancer. 11 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Michels, K. et al. (2023). Preclinical proof of concept for VivoVec, a lentiviral-based platform for in vivo CAR T-cell engineering. Journal for immunotherapy of cancer. 11 (3), p. . [Online].